NAIC INVESTOR'S TOOLKIT DATA =
REPORT=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D
BASIC =
DATA=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Company: Pfizer Inc. Price: 31.730 =
Date: 12/10/2002
Ticker: PFE
Industry: Pharmaceuticals High: 42.500 =
Low: 25.100
Traded: NYSE
Source: Value Line Date: 10/25/2002 =
Total Debt($M): 11438.0
Reference: 1279 Preparer: Don =
Pfd Stock($M): 0.0
=
Pfd Div'd($M): 0.0
Last Full Fiscal Year: 2001
Month Fiscal Year Ends: December
=
Common Shares(M): 6189.7
Analyst's EPS Growth Est.(%): 17.50 Common =
Dividends($): 0.500
Analyst's EPS Est.($): 2.80 % =
Insider Ownership: 0.5
Quality Source: VL Institutional =
Holdings(000): 3806527.0
Quality Rating: A++ Fully =
Diluted Shares(M): 0.000
QUARTERLY =
DATA=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Last Quarter of Data: 3rd Quarter 2002
Quarter Sales EPS PTP Tax%
4th Quarter FY 2000 8105.0 0.27 =20
1st Quarter FY 2001 7645.0 0.33 2600.0 668.0
2nd Quarter FY 2001 7686.0 0.30 2391.0 590.0
3rd Quarter FY 2001 7898.0 0.34 2072.0 0.0
4th Quarter FY 2001 9030.0 0.34 =20
1st Quarter FY 2002 8418.0 0.39 =20
2nd Quarter FY 2002 8033.0 0.33 =20
3rd Quarter FY 2002 8725.0 0.39 2350.0 0.0
ANNUAL =
DATA=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Last Full Fiscal Year: 2001
Year High Low EPS Div'd Bk Val Sales Net =
Prof TaxRate Shrs Out
1992 7.200 5.433 0.27 0.123 1.21 7230.2 =
1093.5 28.6 3902.00
1993 6.300 4.367 0.31 0.140 1.00 7477.7 =
1179.8 26.3 3851.00
1994 6.600 4.433 0.35 0.157 1.15 8281.3 =
1298.4 30.0 3771.00
1995 11.133 6.200 0.41 0.173 1.44 10021.0 =
1554.2 32.1 3824.00
1996 15.200 10.033 0.50 0.200 1.80 11306.0 =
1929.0 31.0 3870.00
1997 26.667 13.433 0.57 0.227 2.04 12504.0 =
2213.0 28.0 3882.00
1998 42.958 23.708 0.67 0.253 2.27 13544.0 =
2633.6 28.0 3882.00
1999 50.000 31.500 0.87 0.310 2.31 16204.0 =
3393.2 28.6 3847.00
2000 49.250 30.000 1.02 0.360 2.55 29574.0 =
6495.0 28.1 6314.00
2001 46.750 34.000 1.31 0.440 2.91 32259.0 =
8349.5 25.2 6277.00
Estimated Tax =
Rate: 16.5
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Prepared using the NAIC Investor's Toolkit. 12/10/2002 11:25:39 PM
NAIC INVESTOR=92S TOOLKIT ANALYSIS =
REPORT=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D12/10/2002
Pfizer Inc. (PFE NYSE) Current Price: 31.7 Current P/E: =
21.9
FY 2001 ended 12/31/2001 Data through 3rd =
quarter FY 2002(9/30/2002)
Prepared by: Don Source of data: Value Line =
(10/25/2002)
Capitalization:=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D
Total Debt ($M): $11,438.0 Debt/Capital: 38.8%
% Insiders % Institution=20
Preferred($M): .0 N/A N/A =20
Common Sh(M): 6,189.7 0.5 61.5 =20
Quarterly Performance (Qtr End 9/30/2002) =
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D
Sales($M) EPS($)
Latest Quarter: 8,725.0 0.39
Year Ago Quarter: 7,898.0 0.34
Percentage Change: 10.5% 14.7%
Section 1 - Annual Historical and Estimated Future Growth Rates =
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D
Historical Sales Growth: 18.1 Outliers: None
Historical EPS Growth: 19.0
Estimated Future Sales Growth: 15.0
Estimated Future EPS Growth: 11.6 Projection started from last =
annual data point
Section 2 Evaluating Management =
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
5 yr.Avg. Trend Outliers
2A % Pre-Tax Profit on Sales: 29.2 UP None
2B % Earned on Equity: 36.0 UP None
Section 3 - Price-Earnings History =
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D
Outliers
3B7 Average Low Price: $ 26.50 None
3D7 Average High P/E: 50.60 None
3E7 Average Low P/E: 30.10 None
3G Average % Payout: 36.50% None
Average P/E: 40.30 Current P/E: 21.90 Projected P/E: =
19.61
Section 4 - Evaluating Risk and Reward =
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D
4A Average High P/E: 50.60
Estimated High EPS 2.27
Forecast High Price: 114.90
4B Average Low P/E: 30.10
4B Estimated Low EPS: 1.31
Selected Estimated Low Price: 26.50
4C Zoning =
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D
26.50 --Buy -- 55.97 --Hold-- 85.43 --Sell-- 114.90=20
Zoning set at: 33%-33%-33%
Current Price of 31.73 is in the 'Buy' range
4D Upside/Downside =
Ratio:=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Upside/Downside Ratio: 15.9
Relative Value: 54.3 Projected Rel. Val.: 48.6
Section 5 - Five-Year Potential =
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
5A Present Yield: 1.6 5B Average Yield: 2.1
5C Total Return(simple): 54.5 Total Return(compounded): 38.0 =
Projected Avg. Ret: 30.8
Preferred Procedure Calculations =
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Default Override
Projected 5 Year Sales @ 15.0% 0.0 64,884.4
Less Expenses 29.2% 0.0 -45,938.1
Less Taxes 25.2% 0.0 -4,774.5
Less Preferred Dividends $0.0 0.0 0.0
=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Projected 5 Yr Total Earnings 14,171.8
Divided by Shares Outs. 6189.7 0.0 2.29
Calculated Growth Rate 11.8
Prepared using the NAIC Investor's Toolkit 12/10/2002 11:25:39 PM